CCM Duopharma Biotech Bhd (CCMDBIO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CCM Duopharma Biotech Bhd (CCMDBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3490
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CCM Duopharma Biotech Bhd (CCMD), a subsidiary of Chemical Company of Malaysia Bhd, is a pharmaceutical company that develops, manufactures and markets generic drugs and branded pharmaceutical products. The company offers products in the form of tablets, capsules, syrup, oral antibiotic, creams, haemodialysis solution, sterile irrigation solution, sterile powder injectables, small volume injectables, dental cartridges and eye drop preparations. It also manufactures small volume injectables through its manufacturing facility in Klang. CCMD exports its products across Vietnam, Ethiopia, Sudan, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore and Hong Kong. The company operates through its subsidiaries in the Philippines, Indonesia and Singapore. CCM Duopharma is headquartered in Klang, Malaysia.

CCM Duopharma Biotech Bhd (CCMDBIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Duopharma Enters into Agreement with PanGen Biotech 10
Licensing Agreements 11
Biocon Enters Into Licensing Agreement With CCM Pharma For Insulin Products 11
Equity Offering 12
CCM Duopharma Biotech Prices Rights Offering of Shares for USD75 Million 12
Acquisition 13
CCM Duopharma Biotech to Acquire 8.39% Stake in Pangen Biotech from Chemical Company of Malaysia for USD9.4 Million 13
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 15
CCM Duopharma Biotech Bhd – Key Competitors 17
CCM Duopharma Biotech Bhd – Key Employees 18
CCM Duopharma Biotech Bhd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Feb 24, 2017: CCM Duopharma Registers Double-Digit Top Line Growth In FY 2016 21
Other Significant Developments 22
May 22, 2017: CCM Duopharma Aims To Become A Leading Regional Player 22
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CCM Duopharma Biotech Bhd, Deals By Therapy Area, 2012 to YTD 2018 8
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duopharma Enters into Agreement with PanGen Biotech 10
Biocon Enters Into Licensing Agreement With CCM Pharma For Insulin Products 11
CCM Duopharma Biotech Prices Rights Offering of Shares for USD75 Million 12
CCM Duopharma Biotech to Acquire 8.39% Stake in Pangen Biotech from Chemical Company of Malaysia for USD9.4 Million 13
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 15
CCM Duopharma Biotech Bhd, Key Competitors 17
CCM Duopharma Biotech Bhd, Key Employees 18
CCM Duopharma Biotech Bhd, Subsidiaries 19

List of Figures
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CCM Duopharma Biotech Bhd (CCMDBIO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vishay Intertechnology Inc (VSH):企業の財務・戦略的SWOT分析
    Vishay Intertechnology Inc (VSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PetroMaroc Corporation Plc (PMA):企業の財務・戦略的SWOT分析
    Summary PetroMaroc Corporation Plc (Petromaroc), formerly Longreach Oil and Gas Ltd, is an oil and gas exploration and development company that evaluates, acquires, explores and develops oil and gas properties in Morocco. The company holds interests in the Sidi Moktar licence area which includes geo …
  • Bioneer Corp (064550):医療機器:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …
  • Cipla Limited:企業の戦略・SWOT・財務分析
    Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sinochem International Corp (600500):企業の財務・戦略的SWOT分析
    Sinochem International Corp (600500) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Dakota Valley Electric Cooperative:企業の戦略的SWOT分析
    Dakota Valley Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Anhui Construction Engineering Group Co., Ltd.:企業の戦略・SWOT・財務情報
    Anhui Construction Engineering Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Anhui Construction Engineering Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務分析
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Newfoundland Power Inc.:企業の戦略的SWOT分析
    Newfoundland Power Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Victek Co., Ltd.:企業の戦略・SWOT・財務分析
    Victek Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Victek Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cellectis SA (ALCLS):医療機器:M&Aディール及び事業提携情報
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Great-West Lifeco Inc.:企業の戦略・SWOT・財務情報
    Great-West Lifeco Inc. - Strategy, SWOT and Corporate Finance Report Summary Great-West Lifeco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Biosceptre International Ltd-医療機器分野:企業M&A・提携分析
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Biosceptre’s diagnostic products are …
  • Veristat LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers services such as clinical project management, data management, clinical monitoring, biostatistics, medical writing, project management, reg …
  • Kenya Electricity Generating Co Ltd:発電所・企業SWOT分析
    Kenya Electricity Generating Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Univision Communications Inc.:企業の戦略的SWOT分析
    Univision Communications Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • AveXis Inc (AVXS):製薬・医療:M&Aディール及び事業提携情報
    Summary AveXis Inc (AveXis), formerly BioLife Cell Bank Inc, is a biotechnology company that develops innovative treatments for rare and potentially fatal neurological genetic diseases. The company offers AVXS-101, a proprietary gene therapy candidate in phase 1 targeted at the treatment of spinal m …
  • AeroMaoz Ltd.:企業の戦略・SWOT・財務情報
    AeroMaoz Ltd. - Strategy, SWOT and Corporate Finance Report Summary AeroMaoz Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ames Construction Inc:企業の戦略的SWOT分析
    Ames Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆